MBL obtained manufacturing and marketing approval on September 14, 2022 for its new GLINE-SARS-CoV-2&FluA+B, a simple test kit that simultaneously detects both the SARS-CoV-2 antigen and influenza virus antigen in a single test cassette. Sales will begin on September 30.
This kit detects the SARS-CoV-2 antigen, influenza A virus antigen, and influenza B virus antigen in nasopharyngeal or nasal swab fluid using an immunochromatographic* method.
*Immunochromatography: A method to test for viral infection by dropping a sample into a kit. Since it uses capillary action, no machine is required for the test, and the test can be performed visually. It is a simple and rapid method that can determine the result within 15~20 minutes after specimen is dropped into the reaction cassette.
A single test cassette is used to test for influenza A and B viruses as well as novel coronaviruses.
The ability to perform both tests with a single specimen collection reduces the burden on patients at the time of sample collection, as well as the testing workload for healthcare professionals.